C M Bidwell & Associates LTD Regeneron Pharmaceuticals, Inc. Transaction History

C M Bidwell & Associates LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$595.12 - $698.43 $149,970 - $176,004	-252 Reduced 55.63%	201 $140,000
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $136,956 - $169,084	252 Added 125.37%	453 $286,000
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $115,380 - $136,872	201 New	201 $122,000
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $69,689 - $85,519	-156 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $171,709 - $218,264	-359 Reduced 69.71%	156 $75,000
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $84,436 - $102,022	-155 Reduced 23.13%	515 $288,000
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $227,420 - $296,847	461 Added 220.57%	670 $418,000
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $70,261 - $103,335	209 New	209 $102,000
Q2 2019 Aug 07, 2019	SELL	$299.6 - $414.82 $155,792 - $215,706	-520 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $5,581 - $6,593	-15 Reduced 2.8%	520 $214,000
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $179,663 - $215,626	535 New	535 $200,000
Q2 2018 Aug 13, 2018	SELL	$284.6 - $344.99 $298,830 - $362,239	-1,050 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$315.82 - $393.78 $15,791 - $19,689	50 Added 5.0%	1,050 $362,000
Q4 2017 Feb 02, 2018	BUY	$358.63 - $469.95 $358,630 - $469,950	1,000	1,000 $376,000

1,484

83.7M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.